PATIENT CAPITAL

A London investment group is aiming to avoid overexposure to frothy conditions in Europe's leveraged loan market - and benefit should it overheat.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.